Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With High LDL-Cholesterol”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02739984
What this trial is testing

Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia

Who this might be right for
HypercholesterolemiaMixed DyslipidemiaType 2 Diabetes
Amgen 424
Testing effectiveness (Phase 2)Study completedNCT00105066
What this trial is testing

The Effects of Metformin on Blood Vessel Structure and Function

Who this might be right for
ObesityHypertensionHypercholesterolemia+1 more
National Institute on Aging (NIA) 77
Testing effectiveness (Phase 2)Ended earlyNCT01004705
What this trial is testing

A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol

Who this might be right for
Elevated LDL Cholesterol
Ferrer Internacional S.A. 36
Large-scale testing (Phase 3)Study completedNCT01953328
What this trial is testing

Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk

Who this might be right for
Hyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular Events
Amgen 409
Early research (Phase 1)Study completedNCT01163851
What this trial is testing

Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With Atorvastatin

Who this might be right for
HypercholesterolemiaDyslipidemia
Pfizer 25
Early research (Phase 1)Study completedNCT01243151
What this trial is testing

Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia

Who this might be right for
HypercholesterolemiaDyslipidemia
Pfizer 68
Large-scale testing (Phase 3)Study completedNCT00654407
What this trial is testing

Mercury II - Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin With Rosuvastatin in High Risk Subjects With Type IIa and IIb Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
AstraZeneca 4,875
Large-scale testing (Phase 3)Study completedNCT00028301
What this trial is testing

Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Post-approval studies (Phase 4)Study completedNCT00645151
What this trial is testing

The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol

Who this might be right for
Dyslipidemias
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 512
Large-scale testing (Phase 3)Study completedNCT03814187
What this trial is testing

Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C

Who this might be right for
ASCVDElevated CholesterolHeterozygous Familial Hypercholesterolemia+1 more
Novartis Pharmaceuticals 3,275
Large-scale testing (Phase 3)Study completedNCT01849497
What this trial is testing

Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/Pen

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Amgen 149
Not applicableUnknownNCT04087915
What this trial is testing

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With High Risk Coronary Artery Disease (FORWARD)

Who this might be right for
DyslipidemiaHigh Risk Coronary Artery Disease
Beijing Anzhen Hospital 1,000
Large-scale testing (Phase 3)Study completedNCT03397121
What this trial is testing

Trial to Evaluate the Effect of Inclisiran Treatment on Low Density Lipoprotein Cholesterol (LDL-C) in Subjects With Heterozygous Familial Hypercholesterolemia (HeFH)

Who this might be right for
Heterozygous Familial HypercholesterolemiaElevated Cholesterol
The Medicines Company 482
Not applicableStudy completedNCT02268318
What this trial is testing

"A Clinical Study for Evaluating the Effect of a Plant Sterol-enriched Fermented Dairy Product on Blood Lipoprotein Profile in Japanese Adults"

Who this might be right for
Subjects With High LDL-Cholesterol
Danone Japan 154
Not applicableStudy completedNCT00099684
What this trial is testing

Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for the Treatment of High Cholesterol in HIV Infected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 44
Testing effectiveness (Phase 2)Study completedNCT01375777
What this trial is testing

Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels

Who this might be right for
Hyperlipidemia
Amgen 411
Large-scale testing (Phase 3)Ended earlyNCT00239681
What this trial is testing

JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events

Who this might be right for
Elevated High-sensitivity C-Reactive Protein (hsCRP)
AstraZeneca 17,802
Early research (Phase 1)Study completedNCT03593785
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD8233 in Healthy Male Subjects With Increased Elevated LDL-C Levels.

Who this might be right for
Hypercholesterolemia
AstraZeneca 73
Testing effectiveness (Phase 2)Study completedNCT00169559
What this trial is testing

Dyslipidemia Study Investigating The Increase In "Good Cholesterol"

Who this might be right for
Dyslipidaemias
GlaxoSmithKline 250
Early research (Phase 1)Study completedNCT03427710
What this trial is testing

A First In Human Study to Assess CiVi007 in Subjects With an Elevated LDL-Cholesterol Level

Who this might be right for
Hypercholesterolemia
Civi Biopharma, Inc. 36
Next Page